Cargando…
The vacuolar-type ATPase inhibitor archazolid increases tumor cell adhesion to endothelial cells by accumulating extracellular collagen
The vacuolar-type H(+)-ATPase (v-ATPase) is the major proton pump that acidifies intracellular compartments of eukaryotic cells. Since the inhibition of v-ATPase resulted in anti-tumor and anti-metastatic effects in different tumor models, this enzyme has emerged as promising strategy against cancer...
Autores principales: | Luong, Betty, Schwenk, Rebecca, Bräutigam, Jacqueline, Müller, Rolf, Menche, Dirk, Bischoff, Iris, Fürst, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133348/ https://www.ncbi.nlm.nih.gov/pubmed/30204757 http://dx.doi.org/10.1371/journal.pone.0203053 |
Ejemplares similares
-
Anti-leukemic effects of the V-ATPase inhibitor Archazolid A
por: Zhang, Siwei, et al.
Publicado: (2015) -
Total syntheses of the archazolids: an emerging class of novel anticancer drugs
por: Scheeff, Stephan, et al.
Publicado: (2017) -
Archazolid and apicularen: Novel specific V-ATPase inhibitors
por: Huss, Markus, et al.
Publicado: (2005) -
Design, Synthesis and Biological Evaluation of Highly Potent Simplified Archazolids
por: Rivière, Solenne, et al.
Publicado: (2020) -
Acidification of endothelial Weibel-Palade bodies is mediated by the vacuolar-type H(+)-ATPase
por: Terglane, Julian, et al.
Publicado: (2022)